カテゴリ： Inkwood Research, 世界, 消費財/食品

セルライトトリートメントのグローバル市場2023〜2032

■ 英語タイトル：GLOBAL CELLULITE TREATMENT MARKET FORECAST 2023-2032

調査会社Inkwood Research社が発行したリサーチレポート（データ管理コード：INK23AP005）■ 発行会社/調査会社：Inkwood Research
■ 商品コード：INK23AP005
■ 発行日：2023年3月24日
   最新版(2025年又は2026年)はお問い合わせください。
■ 調査対象地域：グローバル
■ 産業分野：消費財
■ ページ数：232
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算￥456,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算￥684,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Inkwood Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[セルライトトリートメントのグローバル市場2023〜2032]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Inkwood Research社の市場調査では、セルライトトリートメントの世界市場規模が2023年から2032年の間で年平均9.44%成長すると推測しています。本書では、セルライトトリートメントの世界市場を広く調査・分析し、調査範囲・調査方法、エグゼクティブサマリー、市場動向、主要分析、処置別（ソフトセルライト、ハードセルライト、浮腫性セルライト）分析、エンドユーザー別（病院、診療所・美容院、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、その他）分析、競争状況などの内容を整理しています。並びに、市場調査の対象企業には、ABBVIE INC、ALMA LASERS、BAUSCH HEALTH COMPANIES INC、CANDELA CORPORATION、CUTERA INC、CYNOSURE LLC、ENDO INTERNATIONAL PLC、GALDERMA SA 、INCELER MEDIKAL CO LTD、JOHNSON & JOHNSON などが含まれています。
・調査範囲・調査方法
・エグゼクティブサマリー
・市場動向
・主要分析
・世界のセルライトトリートメント市場規模：処置別
- ソフトセルライトにおける市場規模
- ハードセルライトにおける市場規模
- 浮腫性セルライトにおける市場規模
・世界のセルライトトリートメント市場規模：エンドユーザー別
- 病院における市場規模
- 診療所・美容院における市場規模
- その他エンドユーザーにおける市場規模
・世界のセルライトトリートメント市場規模：地域別
- 北米のセルライトトリートメント市場規模
- ヨーロッパのセルライトトリートメント市場規模
- アジア太平洋のセルライトトリートメント市場規模
- その他地域のセルライトトリートメント市場規模
・競争状況

KEY FINDINGS
The global cellulite treatment market is anticipated to register a CAGR of 9.44% during the forecast period 2023-2032. Some of the key drivers facilitating the market’s growth include the increasing demand for aesthetic and cosmetic procedures, rising cases of obesity, as well as the rapidly booming medical tourism industry.

MARKET INSIGHTS
Cellulite is characterized as fat collections that push against the connective tissue beneath the skin. It appears on the stomach, buttocks, and thighs. Cellulite may be caused due to accumulated toxins, poor diet, genetics, pregnancy, weight gain, and inactivity.
Obesity is one of the leading health concerns globally. Obesity leads to cellulite by virtue of heightening the volume of fat trapped within irregular-sized fat lobules. According to the Centers for Disease Control and Prevention (CDC), obesity prevalence in the United States was more than 41% in 2017. Furthermore, according to the World Health Organization (WHO), approximately 39 million children under the age of 5 were obese or overweight in the year 2020. People with obesity are more vulnerable to health issues like cardiac disorders, diabetes, high blood pressure, strokes, and other conditions. Such health problems encourage individuals to undergo treatment for obesity, thereby facilitating the global cellulite treatment market growth.

REGIONAL INSIGHTS
The global cellulite treatment market growth analysis covers a detailed assessment of North America, Europe, Asia-Pacific, and Rest of World. The Asia-Pacific is set to grow with the highest CAGR during the forecast period. The regional market’s growth is primarily ascribed to the presence of skilled professionals and high-quality healthcare facilities, in addition to the lower cost of treatments and premium healthcare services.

COMPETITIVE INSIGHTS
The degree of industrial rivalry within the global cellulite treatment market is projected to be high during the forecast period. Some of the key companies operating in the market are Johnson & Johnson, AbbVie Inc, Bausch Health Companies Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.5. MAJOR MARKET FINDINGS
2.5.1. RISING BEAUTY CONSCIOUSNESS
2.5.2. GROWING PREFERENCE TOWARDS NON-INVASIVE PROCEDURES
2.5.3. TECHNOLOGICAL ADVANCEMENTS TO PROMOTE MARKET GROWTH
2.5.4. RAPIDLY CHANGING LIFESTYLES LEADING TO OBESITY
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. GROWING DEMAND FOR AESTHETIC AND COSMETIC PROCEDURES
3.1.2. RISING CASES OF OBESITY
3.1.3. RAPIDLY BOOMING MEDICAL TOURISM INDUSTRY
3.2. KEY RESTRAINTS
3.2.1. HIGH COST OF ADVANCED CELLULITE TREATMENT
3.2.2. SIDE EFFECTS POST-TREATMENT
3.2.3. LACK OF AWARENESS
4. KEY ANALYTICS
4.1. PARENT MARKET ANALYSIS
4.2. KEY TECHNOLOGY TRENDS
4.3. PORTER’S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RESEARCH AND DEVELOPMENT
4.7.2. PRODUCT DEVELOPMENT
4.7.3. MARKETING AND DISTRIBUTION
4.7.4. POST-SALES MONITORING
4.8. KEY BUYING CRITERIA
4.8.1. COST
4.8.2. BRAND REPUTATION
4.8.3. USABILITY
5. MARKET BY PROCEDURE
5.1. NON-INVASIVE
5.2. MINIMALLY INVASIVE
5.3. TOPICAL
6. MARKET BY TYPE
6.1. SOFT CELLULITE
6.2. HARD CELLULITE
6.3. EDEMATOUS CELLULITE
7. MARKET BY END-USER
7.1. HOSPITALS
7.2. CLINICS AND BEAUTY CENTERS
7.3. OTHER END-USERS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. NORTH AMERICA CELLULITE TREATMENT MARKET DRIVERS
8.1.3. NORTH AMERICA CELLULITE TREATMENT MARKET CHALLENGES
8.1.4. NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.1.5. KEY PLAYERS IN NORTH AMERICA CELLULITE TREATMENT MARKET
8.1.6. COUNTRY ANALYSIS
8.1.6.1. UNITED STATES
8.1.6.1.1. UNITED STATES CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.1.6.2. CANADA
8.1.6.2.1. CANADA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. EUROPE CELLULITE TREATMENT MARKET DRIVERS
8.2.3. EUROPE CELLULITE TREATMENT MARKET CHALLENGES
8.2.4. EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.2.5. KEY PLAYERS IN EUROPE CELLULITE TREATMENT MARKET
8.2.6. COUNTRY ANALYSIS
8.2.6.1. UNITED KINGDOM
8.2.6.1.1. UNITED KINGDOM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.2. GERMANY
8.2.6.2.1. GERMANY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.3. FRANCE
8.2.6.3.1. FRANCE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.4. ITALY
8.2.6.4.1. ITALY CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.5. BELGIUM
8.2.6.5.1. BELGIUM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.6. POLAND
8.2.6.6.1. POLAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.2.6.7. REST OF EUROPE
8.2.6.7.1. REST OF EUROPE CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. ASIA-PACIFIC CELLULITE TREATMENT MARKET DRIVERS
8.3.3. ASIA-PACIFIC CELLULITE TREATMENT MARKET CHALLENGES
8.3.4. ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.3.5. KEY PLAYERS IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
8.3.6. COUNTRY ANALYSIS
8.3.6.1. CHINA
8.3.6.1.1. CHINA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.2. JAPAN
8.3.6.2.1. JAPAN CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.3. INDIA
8.3.6.3.1. INDIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.4. SOUTH KOREA
8.3.6.4.1. SOUTH KOREA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.5. THAILAND
8.3.6.5.1. THAILAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.6. INDONESIA
8.3.6.6.1. INDONESIA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.7. VIETNAM
8.3.6.7.1. VIETNAM CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.8. AUSTRALIA & NEW ZEALAND
8.3.6.8.1. AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.3.6.9. REST OF ASIA-PACIFIC
8.3.6.9.1. REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. REST OF WORLD CELLULITE TREATMENT MARKET DRIVERS
8.4.3. REST OF WORLD CELLULITE TREATMENT MARKET CHALLENGES
8.4.4. REST OF WORLD CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
8.4.5. KEY PLAYERS IN REST OF WORLD CELLULITE TREATMENT MARKET
8.4.6. REGIONAL ANALYSIS
8.4.6.1. LATIN AMERICA
8.4.6.1.1. LATIN AMERICA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
8.4.6.2. MIDDLE EAST & AFRICA
8.4.6.2.1. MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABBVIE INC
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. FINANCIAL ANALYSIS
9.2.1.3. PRODUCTS / SERVICES LIST
9.2.1.4. STRENGTHS & CHALLENGES
9.2.2. ALMA LASERS
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCTS / SERVICES LIST
9.2.3. BAUSCH HEALTH COMPANIES INC.
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. FINANCIAL ANALYSIS
9.2.3.3. PRODUCTS / SERVICES LIST
9.2.3.4. STRENGTHS & CHALLENGES
9.2.4. CANDELA CORPORATION
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCTS / SERVICES LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. CUTERA INC
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. FINANCIAL ANALYSIS
9.2.5.3. PRODUCTS / SERVICES LIST
9.2.5.4. STRENGTHS & CHALLENGES
9.2.6. CYNOSURE LLC
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCTS / SERVICES LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. ENDO INTERNATIONAL PLC
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. FINANCIAL ANALYSIS
9.2.7.3. PRODUCTS / SERVICES LIST
9.2.7.4. STRENGTHS & CHALLENGES
9.2.8. GALDERMA SA
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCTS / SERVICES LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. INCELER MEDIKAL CO LTD
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCTS / SERVICES LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. JOHNSON & JOHNSON
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. FINANCIAL ANALYSIS
9.2.10.3. PRODUCTS / SERVICES LIST
9.2.10.4. STRENGTHS & CHALLENGES
9.2.11. MERZ PHARMA GMBH & CO KGAA
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCTS / SERVICES LIST
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. NUBWAY CO LTD
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCTS / SERVICES LIST
9.2.13. SIENTRA INC
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. FINANCIAL ANALYSIS
9.2.13.3. PRODUCTS / SERVICES LIST
9.2.13.4. STRENGTHS & CHALLENGES
9.2.14. SINCLAIR PHARMA
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCTS / SERVICES LIST
9.2.15. ZIMMER MEDIZINSYSTEME
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCTS / SERVICES LIST
9.2.15.3. STRENGTHS & CHALLENGES

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – CELLULITE TREATMENT
TABLE 2: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: GLOBAL CELLULITE TREATMENT MARKET, BY PROCEDURE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 4: GLOBAL NON-INVASIVE CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: GLOBAL NON-INVASIVE CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 6: GLOBAL MINIMALLY INVASIVE CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: GLOBAL MINIMALLY INVASIVE CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 8: GLOBAL TOPICAL CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: GLOBAL TOPICAL CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 10: GLOBAL CELLULITE TREATMENT MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: GLOBAL CELLULITE TREATMENT MARKET, BY TYPE, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 12: GLOBAL SOFT CELLULITE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: GLOBAL SOFT CELLULITE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 14: GLOBAL HARD CELLULITE MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: GLOBAL HARD CELLULITE MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 16: GLOBAL EDEMATOUS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: GLOBAL EDEMATOUS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 18: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 19: GLOBAL CELLULITE TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 20: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 21: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 22: GLOBAL CLINICS AND BEAUTY CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 23: GLOBAL CLINICS AND BEAUTY CENTERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 24: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 25: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 26: GLOBAL CELLULITE TREATMENT MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 27: GLOBAL CELLULITE TREATMENT MARKET, BY GEOGRAPHY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 28: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 29: NORTH AMERICA CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 30: NORTH AMERICA CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 31: LEADING PLAYERS OPERATING IN NORTH AMERICA CELLULITE TREATMENT MARKET
TABLE 32: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 33: EUROPE CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 34: EUROPE CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 35: LEADING PLAYERS OPERATING IN EUROPE CELLULITE TREATMENT MARKET
TABLE 36: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 37: ASIA-PACIFIC CELLULITE TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 38: ASIA-PACIFIC CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 39: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CELLULITE TREATMENT MARKET
TABLE 40: REST OF WORLD CELLULITE TREATMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 41: REST OF WORLD CELLULITE TREATMENT MARKET, BY REGION, FORECAST YEARS, 2023-2032 (IN $ MILLION)
TABLE 42: REST OF WORLD CELLULITE TREATMENT MARKET REGULATORY FRAMEWORK
TABLE 43: LEADING PLAYERS OPERATING IN REST OF WORLD CELLULITE TREATMENT MARKET
TABLE 44: LIST OF ACQUISITIONS
TABLE 45: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 46: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 47: LIST OF EXPANSIONS & DIVESTITURES


LIST OF FIGURES
FIGURE 1: KEY TECHNOLOGY TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY PROCEDURE, IN 2022
FIGURE 9: GLOBAL CELLULITE TREATMENT MARKET, BY NON-INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 10: GLOBAL CELLULITE TREATMENT MARKET, BY MINIMALLY INVASIVE, 2023-2032 (IN $ MILLION)
FIGURE 11: GLOBAL CELLULITE TREATMENT MARKET, BY TOPICAL, 2023-2032 (IN $ MILLION)
FIGURE 12: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY TYPE, IN 2022
FIGURE 13: GLOBAL CELLULITE TREATMENT MARKET, BY SOFT CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 14: GLOBAL CELLULITE TREATMENT MARKET, BY HARD CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 15: GLOBAL CELLULITE TREATMENT MARKET, BY EDEMATOUS CELLULITE, 2023-2032 (IN $ MILLION)
FIGURE 16: GLOBAL CELLULITE TREATMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2022
FIGURE 17: GLOBAL CELLULITE TREATMENT MARKET, BY HOSPITALS, 2023-2032 (IN $ MILLION)
FIGURE 18: GLOBAL CELLULITE TREATMENT MARKET, BY CLINICS AND BEAUTY CENTERS, 2023-2032 (IN $ MILLION)
FIGURE 19: GLOBAL CELLULITE TREATMENT MARKET, BY OTHER END-USERS, 2023-2032 (IN $ MILLION)
FIGURE 20: NORTH AMERICA CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 21: UNITED STATES CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 22: CANADA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 23: EUROPE CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN %)
FIGURE 24: UNITED KINGDOM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 25: GERMANY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 26: FRANCE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 27: ITALY CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 28: BELGIUM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 29: POLAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 30: REST OF EUROPE CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 31: ASIA-PACIFIC CELLULITE TREATMENT MARKET, COUNTRY OUTLOOK, 2022 & 2032 (IN%)
FIGURE 32: CHINA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 33: JAPAN CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 34: INDIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 35: SOUTH KOREA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 36: THAILAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 37: INDONESIA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 38: VIETNAM CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 39: AUSTRALIA & NEW ZEALAND CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 40: REST OF ASIA-PACIFIC CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 41: REST OF WORLD CELLULITE TREATMENT MARKET, REGIONAL OUTLOOK, 2022 & 2032 (IN %)
FIGURE 42: LATIN AMERICA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 43: MIDDLE EAST & AFRICA CELLULITE TREATMENT MARKET, 2023-2032 (IN $ MILLION)
FIGURE 44: ABBVIE INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 45: ABBVIE INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 46: ABBVIE INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 47: BAUSCH HEALTH COMPANIES INC COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 48: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 49: BAUSCH HEALTH COMPANIES INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 50: CUTERA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)
FIGURE 51: CUTERA INC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 52: CUTERA INC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 53: ENDO INTERNATIONAL PLC COMPANY PROFIT 2018 - 2021 ($ MILLION)
FIGURE 54: ENDO INTERNATIONAL PLC COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 55: ENDO INTERNATIONAL PLC COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 56: JOHNSON & JOHNSON COMPANY PROFIT 2017 - 2021 ($ BILLION)
FIGURE 57: JOHNSON & JOHNSON COMPANY REVENUE – BY GEOGRAPHY, FY 2021-22 (IN %)
FIGURE 58: JOHNSON & JOHNSON COMPANY REVENUE – BY SEGMENT, 2021 (IN %)
FIGURE 59: JOHNSON & JOHNSON COMPANY REVENUE 2017 - 2021 ($ BILLION)
FIGURE 60: SIENTRA INC COMPANY PROFIT 2017 - 2021 ($ MILLION)

※参考情報

セルライトトリートメントは、皮膚の下に存在する脂肪細胞が肥大化し、結合組織の変化によって「オレンジの皮」のような凹凸が見える状態、つまりセルライトを減少させるためのさまざまな治療法を指します。この現象は特に女性に多く見られ、体重に関係なく発生することがあるため、多くの人々がこの問題に悩んでいます。セルライトはその見た目が良くないことから、外見を気にする人々にとって大きな悩みの一つです。

セルライトトリートメントには、多様な種類がありますが、以下に代表的なものを紹介します。

まず、マッサージ療法があります。これは、リンパの流れを促進し、血行を良くすることでセルライトの減少を目指す技術です。特にコーヒーやハーブオイルを使ったアプローチが人気で、手技を通じて脂肪の燃焼を促すことが期待されます。

次に、機械を使用したトリートメントも広く行われています。たとえば、キャビテーションやラジオ波を利用したトリートメントがあります。キャビテーションは、超音波を利用して脂肪細胞を破壊し、セルライトを減少させる方法です。一方、ラジオ波のトリートメントは、肌の深層にエネルギーを伝え、脂肪の溶解を促進することで効果を狙います。

さらに、EMS（電気筋肉刺激）を使用したトリートメントもあります。これは、電流を用いて筋肉を刺激し、代謝を上げることで脂肪の燃焼を促すものです。筋肉を引き締めながらセルライトにアプローチできるため、相乗効果が期待されます。

最近では、脂肪吸引や脂肪溶解注射といった外科的手法もally利用されるようになっています。脂肪吸引は、脂肪細胞を物理的に取り除く方法であり、一度の施術で劇的な変化をもたらすことができます。脂肪溶解注射は、脂肪を分解する成分を直接身体に注入することで、セルライトを改善するものです。

セルライトトリートメントの用途は、主に美容面に関連しています。見た目に自信を持ちたい、ボディラインを整えたいと考える人々が、その改善を目指して利用します。また、セルライトは体重やマッサージの効果によって変動しやすいものですので、継続的なケアが求められます。これは、トリートメントを単発で受けるのではなく、定期的に行うことでより効果的になると言われています。

関連技術としては、予防的なアプローチもあります。健康的な食事や適度な運動は、セルライトを未然に防ぐために非常に重要です。特に、代謝を高めるために筋肉をつけることや、水分をしっかりと摂取することも有効です。これらの習慣を生活に取り入れることで、セルライトができにくい環境を整えることができます。

最後に、セルライトトリートメントは個人差が大きく、効果も人によって異なります。これは、遺伝的要因、ライフスタイル、ホルモンバランスなど、多くの要因が複雑に絡み合っているためです。したがって、トリートメントを始める前には、自分の肌の状態や体質を理解した上で、専門家と相談しながら進めることが重要です。適切な方法を選ぶことで、目指すボディラインに近づくことができるでしょう。セルライトトリートメントは、見た目の改善だけでなく、自信をもたらす手段でもあるのです。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • セルライトトリートメントのアジア太平洋市場2023〜2032
  • 食物繊維のグローバル市場2023〜2032
  • 水質モニタリングのアジア太平洋市場2023〜2032
  • 水質モニタリングのグローバル市場2023〜2032
  • 医療用紙のグローバル市場2023〜2032
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(INK23AP005 )"セルライトトリートメントのグローバル市場2023〜2032" (英文：GLOBAL CELLULITE TREATMENT MARKET FORECAST 2023-2032)はInkwood Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。